Rutgers: COVID-19 Vaccine Receives Emergency Use Authorization for Children Ages 5 to 11
November 03, 2021
November 03, 2021
NEW BRUNSWICK, New Jersey, Nov. 3 (TNSRes) -- Rutgers University issued the following news:
* * *
Simon Li, a principal investigator in the Rutgers pediatric clinical trial for the Pfizer-BioNTech COVID-19 vaccine, addresses parents' questions
* * *
Some 28 million children ages 5 to 11 can now get the Pfizer-BioNTech COVID-19 vaccine under emergency use authorization granted by The Food and Drug Administration and Centers for Disease Cont . . .
* * *
Simon Li, a principal investigator in the Rutgers pediatric clinical trial for the Pfizer-BioNTech COVID-19 vaccine, addresses parents' questions
* * *
Some 28 million children ages 5 to 11 can now get the Pfizer-BioNTech COVID-19 vaccine under emergency use authorization granted by The Food and Drug Administration and Centers for Disease Cont . . .